Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hybrid Public Option? Proposal For New State Insurance Plan Passes Cmte.

Executive Summary

A proposed new basic insurance plan targeting a subsection of the uninsured would allow states to negotiate prices with drug manufacturers that could be higher than the Medicaid rates currently paid by states, under an amendment approved by the Senate Finance Committee Oct. 1

You may also be interested in...



Opt-In/Opt-Out Public Plan Gains Momentum Among Range Of Senate Dems

A public option proposal that would allow states to either opt in or out of a national health plan is gaining momentum in the Senate among conservative and liberal Democrats alike, indicating a compromise may be close on one of the most controversial issues of health reform

Opt-In/Opt-Out Public Plan Gains Momentum Among Range Of Senate Dems

A public option proposal that would allow states to either opt in or out of a national health plan is gaining momentum in the Senate among conservative and liberal Democrats alike, indicating a compromise may be close on one of the most controversial issues of health reform

Opt-In/Opt-Out Public Plan Gains Momentum In Senate Among Liberal And Conservative Dems

Tribes of Democrats in the Senate are beginning to coalesce around flexible public options being discussed in conference.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS051542

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel